Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm

Purpose. To determine the efficacy and safety of 23G transconjunctival sutureless vitrectomy, subretinal injection of tissue plasminogen activator using the EVA Surgical System, and pneumatic displacement with air to treat submacular hemorrhages. Methods. Retrospective analysis of 93 eyes surgically...

Full description

Saved in:
Bibliographic Details
Main Authors: Yasmin Ali Said, Evelien Dewilde, Peter Stalmans
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2021/3160963
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547611711635456
author Yasmin Ali Said
Evelien Dewilde
Peter Stalmans
author_facet Yasmin Ali Said
Evelien Dewilde
Peter Stalmans
author_sort Yasmin Ali Said
collection DOAJ
description Purpose. To determine the efficacy and safety of 23G transconjunctival sutureless vitrectomy, subretinal injection of tissue plasminogen activator using the EVA Surgical System, and pneumatic displacement with air to treat submacular hemorrhages. Methods. Retrospective analysis of 93 eyes surgically treated for submacular hemorrhage caused by neovascular AMD or retinal macroaneurysms. Main Outcome Measures. Postoperative visual acuity and surgical complications. Results. After surgery, visual acuity improved after 6 weeks but decreased again at the final postoperative visit at 8 months due to progression of the underlying disease. Complications consisted of 2 cases of retinal pigment epithelial tear, 7 vitreous hemorrhages, 4 hyphema, 6 cases of retinal detachment, and 2 subchoroidal hemorrhages during the follow-up period. Conclusions. This study suggests that a surgical approach with 23G vitrectomy, subretinal tPA injection, and pneumatic displacement using air may be an effective procedure for submacular hemorrhage displacement in patients with AMD and retinal macroaneurysms. However, visual outcome is limited by the underlying macular pathology. Larger multicenter randomized controlled studies are warranted to determine the therapeutic effect of this surgical approach.
format Article
id doaj-art-f1d92dbf44b94e79b0d9e6fcda9678ec
institution Kabale University
issn 2090-0058
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-f1d92dbf44b94e79b0d9e6fcda9678ec2025-02-03T06:44:14ZengWileyJournal of Ophthalmology2090-00582021-01-01202110.1155/2021/3160963Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or MacroaneurysmYasmin Ali Said0Evelien Dewilde1Peter Stalmans2Department of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologyPurpose. To determine the efficacy and safety of 23G transconjunctival sutureless vitrectomy, subretinal injection of tissue plasminogen activator using the EVA Surgical System, and pneumatic displacement with air to treat submacular hemorrhages. Methods. Retrospective analysis of 93 eyes surgically treated for submacular hemorrhage caused by neovascular AMD or retinal macroaneurysms. Main Outcome Measures. Postoperative visual acuity and surgical complications. Results. After surgery, visual acuity improved after 6 weeks but decreased again at the final postoperative visit at 8 months due to progression of the underlying disease. Complications consisted of 2 cases of retinal pigment epithelial tear, 7 vitreous hemorrhages, 4 hyphema, 6 cases of retinal detachment, and 2 subchoroidal hemorrhages during the follow-up period. Conclusions. This study suggests that a surgical approach with 23G vitrectomy, subretinal tPA injection, and pneumatic displacement using air may be an effective procedure for submacular hemorrhage displacement in patients with AMD and retinal macroaneurysms. However, visual outcome is limited by the underlying macular pathology. Larger multicenter randomized controlled studies are warranted to determine the therapeutic effect of this surgical approach.http://dx.doi.org/10.1155/2021/3160963
spellingShingle Yasmin Ali Said
Evelien Dewilde
Peter Stalmans
Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm
Journal of Ophthalmology
title Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm
title_full Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm
title_fullStr Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm
title_full_unstemmed Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm
title_short Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm
title_sort visual outcome after vitrectomy with subretinal tpa injection to treat submacular hemorrhage secondary to age related macular degeneration or macroaneurysm
url http://dx.doi.org/10.1155/2021/3160963
work_keys_str_mv AT yasminalisaid visualoutcomeaftervitrectomywithsubretinaltpainjectiontotreatsubmacularhemorrhagesecondarytoagerelatedmaculardegenerationormacroaneurysm
AT eveliendewilde visualoutcomeaftervitrectomywithsubretinaltpainjectiontotreatsubmacularhemorrhagesecondarytoagerelatedmaculardegenerationormacroaneurysm
AT peterstalmans visualoutcomeaftervitrectomywithsubretinaltpainjectiontotreatsubmacularhemorrhagesecondarytoagerelatedmaculardegenerationormacroaneurysm